Cost-effectiveness of losartan in patients with hypertension and LVH: An economic evaluation for the Netherlands based on the LIFE-study

被引：1
|
作者：
Boersma, C
Carides, GW
Burke, TA
Postma, MJ
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] Merck Res Labs, Blue Bell, PA USA
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67611-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A150 / A151
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study
    Kaur, Gunjeet
    Chauhan, Akashdeep Singh
    Prinja, Shankar
    Teerawattananon, Yot
    Muniyandi, Malaisamy
    Rastogi, Ashu
    Jyani, Gaurav
    Nagarajan, Karikalan
    Lakshmi, P. V. M.
    Gupta, Ankur
    Selvam, Jerard M.
    Bhansali, Anil
    Jain, Sanjay
    LANCET PUBLIC HEALTH, 2022, 7 (01): : E65 - E73
  • [22] The Rationale for Economic Evaluation in Speech and Language: Cost, Effectiveness, and Cost-effectiveness
    Hoch, Jeffrey S.
    Smith, Bridgette P.
    Kim, Jiyeong
    Dewa, Carolyn S.
    SEMINARS IN SPEECH AND LANGUAGE, 2022, 43 (03) : 208 - 217
  • [23] Health economic evaluation of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study
    Takura, Tomoyuki
    Hiramatsu, Makoto
    Nakamoto, Hidetomo
    Kuragano, Takahiro
    Minakuchi, Jun
    Ishida, Hironori
    Nakayama, Masaaki
    Takahashi, Susumu
    Kawanishi, Hideki
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 579 - 590
  • [24] COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS
    Diamantopoulos, A.
    Kievit, W.
    De Vries, R.
    Pompen, M.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A311
  • [25] A first evaluation of the cost-effectiveness of CSII versus MDI in type 2 patients: projection of clinical and economic benefits in the Netherlands
    Roze, S.
    de Portu, S.
    Reznik, Y.
    de Brouwer, B. F. E.
    de Valk, H. W.
    DIABETOLOGIA, 2015, 58 : S26 - S26
  • [26] Cost-effectiveness of renal denervation therapy for the treatment of resistant hypertension in The Netherlands
    Henry, Thea L.
    De Brouwer, Bonnie F. E.
    Van Keep, Marjolijn M. L.
    Blankestijn, Peter J.
    Bots, Michiel L.
    Koffijberg, Hendrik
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (01) : 76 - 87
  • [27] QUALITY-OF-LIFE AND COST-EFFECTIVENESS IN THE TREATMENT OF HYPERTENSION
    WIKLUND, I
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1994, 19 (02) : 81 - 87
  • [28] Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial
    Thurston, S. J.
    Heeg, B.
    de Charro, F.
    van Hout, B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 641 - 651
  • [29] The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure
    Dasbach, EJ
    Rich, MW
    Segal, R
    Gerth, WC
    Carides, GW
    Cook, JR
    Murray, JF
    Snavely, DB
    Pitt, B
    CARDIOLOGY, 1999, 91 (03) : 189 - 194
  • [30] Losartan effectiveness in arterial hypertension patients (ELLA study)
    Chazova, I. E.
    Chikhladze, N. M.
    Belousov, Yu. B.
    Egorova, N. A.
    Sibakova, O. A.
    Sakhnova, T. A.
    Yarovaya, E. B.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (02): : 5 - +
12345